Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 201

1.

Complications and treatment of patients with β-thalassemia in France: results of the National Registry.

Thuret I, Pondarré C, Loundou A, Steschenko D, Girot R, Bachir D, Rose C, Barlogis V, Donadieu J, de Montalembert M, Hagege I, Pegourie B, Berger C, Micheau M, Bernaudin F, Leblanc T, Lutz L, Galactéros F, Siméoni MC, Badens C.

Haematologica. 2010 May;95(5):724-9. doi: 10.3324/haematol.2009.018051. Epub 2009 Dec 8.

2.

Complications of beta-thalassemia major in North America.

Cunningham MJ, Macklin EA, Neufeld EJ, Cohen AR; Thalassemia Clinical Research Network.

Blood. 2004 Jul 1;104(1):34-9. Epub 2004 Feb 26.

3.

Treatment and complications of thalassemia major in Guangxi, Southern China.

Yin XL, Wu ZK, He YY, Zhou TH, Zhou YL, Zhang XH.

Pediatr Blood Cancer. 2011 Dec 15;57(7):1174-8. doi: 10.1002/pbc.23101. Epub 2011 Mar 10.

PMID:
21394896
4.

Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.

Koren A, Fink D, Admoni O, Tennenbaum-Rakover Y, Levin C.

Eur J Haematol. 2010 Jan 1;84(1):72-8. doi: 10.1111/j.1600-0609.2009.01342.x.

PMID:
19732137
7.

Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.

Belhoul KM, Bakir ML, Saned MS, Kadhim AM, Musallam KM, Taher AT.

Ann Hematol. 2012 Jul;91(7):1107-14. doi: 10.1007/s00277-012-1412-7. Epub 2012 Jan 28.

PMID:
22281991
8.

Survival and complications in thalassemia.

Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, Ghilardi R, Origa R, Piga A, Romeo MA, Zhao H, Cnaan A.

Ann N Y Acad Sci. 2005;1054:40-7. Review.

PMID:
16339650
9.

Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.

Shalitin S, Carmi D, Weintrob N, Phillip M, Miskin H, Kornreich L, Zilber R, Yaniv I, Tamary H.

Eur J Haematol. 2005 Feb;74(2):93-100.

PMID:
15654898
10.

[Beta-thalassemia in Germany. Results of cooperative beta-thalassemia study].

Cario H, Stahnke K, Kohne E.

Klin Padiatr. 1999 Nov-Dec;211(6):431-7. German.

PMID:
10592921
11.

[Relationship between growth disorders and iron overload in children with beta-thalassemia major].

Huang YL, Liu S, Xia T, Hao WG, Liang W, Sun X.

Zhongguo Dang Dai Er Ke Za Zhi. 2008 Oct;10(5):603-6. Chinese.

PMID:
18947480
12.

Complications of β-thalassemia intermedia in Iran during 1996-2010 (single-center study).

Rafsanjani KA, Mafi N, Tafreshi RI.

Pediatr Hematol Oncol. 2011 Sep;28(6):497-508. doi: 10.3109/08880018.2011.572144. Epub 2011 Jul 5.

PMID:
21728720
13.

Endocrinopathies in patients with transfusion-dependent beta-thalassemia.

Mehrvar A, Azarkeivan A, Faranoush M, Mehrvar N, Saberinedjad J, Ghorbani R, Vossough P.

Pediatr Hematol Oncol. 2008 Apr-May;25(3):187-94. doi: 10.1080/08880010801938207.

PMID:
18432501
14.
15.

Thyroid function in thalassaemia major.

Senanayake MP, Suraweera SA, Hubert HD.

Ceylon Med J. 1999 Dec;44(4):166-8.

PMID:
10895267
16.

Hepatitis C in patients with β-thalassemia major. A single-centre experience.

Triantos C, Kourakli A, Kalafateli M, Giannakopoulou D, Koukias N, Thomopoulos K, Lampropoulou P, Bartzavali C, Fragopanagou H, Kagadis GC, Christofidou M, Tsamandas A, Nikolopoulou V, Karakantza M, Labropoulou-Karatza C.

Ann Hematol. 2013 Jun;92(6):739-46. doi: 10.1007/s00277-013-1692-6. Epub 2013 Feb 15.

PMID:
23412560
17.

Oral chelators in transfusion-dependent thalassemia major patients may prevent or reverse iron overload complications.

Farmaki K, Tzoumari I, Pappa C.

Blood Cells Mol Dis. 2011 Jun 15;47(1):33-40. doi: 10.1016/j.bcmd.2011.03.007. Epub 2011 Apr 29.

PMID:
21531154
18.

Endocrine complications in patients with Thalassaemia Major.

Toumba M, Sergis A, Kanaris C, Skordis N.

Pediatr Endocrinol Rev. 2007 Dec;5(2):642-8. Review.

PMID:
18084158
19.

Survival, mortality, and complications in patients with beta-thalassemia major in northern Taiwan.

Chern JP, Su S, Lin KH, Chang SH, Lu MY, Jou ST, Lin DT, Ho WL, Lin KS.

Pediatr Blood Cancer. 2007 May;48(5):550-4.

PMID:
16972241
20.

Morbidities and mortality in transfusion-dependent Beta-thalassemia patients (single-center experience).

Mokhtar GM, Gadallah M, El Sherif NH, Ali HT.

Pediatr Hematol Oncol. 2013 Mar;30(2):93-103. doi: 10.3109/08880018.2012.752054. Epub 2013 Jan 9.

PMID:
23301991

Supplemental Content

Support Center